United Kingdom · 
Who invested in Oxford Drug Design Limited?
Oxford Drug Design Limited's investors include ACF Investors and O2h Ventures.
United Kingdom · Funded startup
Who invested in Oxford Drug Design Limited
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$2.8Mraised across 1 round since 2019, from 1 source
- Latest round
- Round, $2.8MNov 2019
- Investors
- 2
The rounds
- Nov 2019
Funding filed with regulators
Oxford Drug Design Limited filed 6 raises, $3.3M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jul 2026$154KUK share allotment
- Jun 2026$309KUK share allotment
- Dec 2025Amount not statedUK share allotment
- Jun 2022$1.2MUK share allotment
- Mar 2022$328KUK share allotment
- Jan 2022$1.3MUK share allotment
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Oxford Drug Design Limited
How much has Oxford Drug Design Limited raised?
Oxford Drug Design Limited has raised $2.8M across 1 round since 2019.
When did Oxford Drug Design Limited last raise?
Oxford Drug Design Limited's most recent round was an Undisclosed round of $2.8M in Nov 2019.
What was Oxford Drug Design Limited's biggest round?
Its most recent round, $2.8M in Nov 2019, is also its largest on record.
Who backed Oxford Drug Design Limited first?
Oxford Drug Design Limited's first round on record, in Nov 2019, was backed by ACF Investors and O2h Ventures.
What stage is Oxford Drug Design Limited at?
Oxford Drug Design Limited's latest named round is an Undisclosed round, in Nov 2019.
Where is Oxford Drug Design Limited based?
Oxford Drug Design Limited is based in the United Kingdom.
Companies like Oxford Drug Design Limited
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.